GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » Cash Ratio

Medacta Group (XSWX:MOVE) Cash Ratio : 0.13 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Medacta Group's Cash Ratio for the quarter that ended in Jun. 2024 was 0.13.

Medacta Group has a Cash Ratio of 0.13. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Medacta Group's Cash Ratio or its related term are showing as below:

XSWX:MOVE' s Cash Ratio Range Over the Past 10 Years
Min: 0.13   Med: 0.24   Max: 0.36
Current: 0.13

During the past 9 years, Medacta Group's highest Cash Ratio was 0.36. The lowest was 0.13. And the median was 0.24.

XSWX:MOVE's Cash Ratio is ranked worse than
88.51% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: 1.08 vs XSWX:MOVE: 0.13

Medacta Group Cash Ratio Historical Data

The historical data trend for Medacta Group's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Cash Ratio Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only 0.23 0.33 0.15 0.36 0.14

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.36 0.25 0.14 0.13

Competitive Comparison of Medacta Group's Cash Ratio

For the Medical Devices subindustry, Medacta Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Medacta Group's Cash Ratio falls into.



Medacta Group Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Medacta Group's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=19.608/140.915
=0.14

Medacta Group's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=20.854/159.534
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group  (XSWX:MOVE) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Medacta Group Cash Ratio Related Terms

Thank you for viewing the detailed overview of Medacta Group's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.